CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation

2 mins read

On 9 November 2021, the 18th Annual CPhI Pharma Awards will take place in Milan, Italy at the Stella Polare Convention Centre. The CPhI Pharma Awards celebrate innovators and thought leaders breaking new ground in the pharma and biopharma industries, and their commitment to advancing new approaches, processes and technologies.

Held as part of CPhI Worldwide (9-11 November 2021), the world’s largest pharma exhibition, these prestigious awards recognise the individuals, teams and companies who turn inspiration into innovation.  Spanning the entire pharmaceutical supply chain, the awards features 15 categories and are renowned across the pharma and biopharma industries as a celebration of industry’s best and brightest.

“We host our awards because it’s important to recognise the innovative and inspirational work that is produced across the pharmaceutical industry” said Tara Dougal, Head of Content & Insights, Informa Markets. “After a challenging year, the industry has been more committed than ever to advancing health and improving patient outcomes. We are incredibly impressed by everything that has been achieved in the 12-months and, consequently, we expect many outstanding entries this year. It’s been a year in which we have seen the very best of pharma, with a record pace of innovation, discovery and commercialization.”

The CPhI Pharma Awards, which launched in 2003, are open to all pharmaceutical and biopharmaceutical companies engaged in aspects of the design, development, manufacture, supply and distribution of large and small molecule drug products. The winners will be selected by an expert panel of judges and the awards cover a wide spectrum of activities; from API Development and Finished Formulations to Manufacturing Technology and Equipment, Contract Services, and Bioprocessing and more.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous Story

Understanding the Link Between Alcohol and Depression

Next Story

FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Endometrial Carcinoma